0000000000308859

AUTHOR

Stefan Kommoss

showing 2 related works from this author

786 Fertility-sparing and minimally invasive surgery in patients with stage I malignant ovarian germ cell tumours in Germany

2021

Introduction/Background* Malignant ovarian germ cell tumours (OGCT) often affect women of younger age at an early stage of disease who may desire fertility conservation. The Arbeitsgemeinschaft fuer Gynaekologische Onkologie (AGO) has established a clinicopathological (Current Ovarian geRm cell and SEx cord stromal Tumour Treatment strategies, CORSETT) database to describe treatment strategies and outcomes for these women. Methodology 20 German centres entered mixed retro- and prospective data of 56 FIGO stage I OGCT patients treated between 2000 to 2014 into the CORSETT database. An independent CORSETT pathology reference panel re-evaluated the primary histological diagnosis. A descriptive…

Gynecologymedicine.medical_specialtyPregnancyendocrine system diseasesmedicine.diagnostic_testbusiness.industrymedicine.diseasemedicine.anatomical_structuremedicineDysgerminomaIn patientCystTeratomaStage (cooking)LaparoscopybusinessGerm cellFertility pregnancy
researchProduct

382 Molecular classification of endometrial carcinoma substantially changing risk-assessment: Results from a european multicentre initiative

2021

Introduction/Background* Endometrial carcinoma patient care was based on histopathologic examination for many years. However, conventional pathologic features are known to suffer from high inter-observer variability and may be irreproducible in many cases. TCGA-derived molecular classification was shown to provide clinically meaningful data and was recently introduced to ESGO/ESTRO/ESP endometrial carcinoma consensus guidelines. It was the aim of this study to quantify alterations in risk-assessment if molecular classification is added to conventional prognosticators. Methodology Consecutive primary endometrial carcinoma patients diagnosed in 2016 were identified in participating centres. O…

medicine.medical_specialtybusiness.industryGynecologic oncologyDiseasePrecision medicineLower riskmedicine.diseaseMSH6Internal medicineCarcinomaMedicineStage (cooking)businessRisk assessmentEndometrial cancer
researchProduct